Published on 25 May 2024 on Simply Wall St. via Yahoo Finance
It's Unlikely That Amgen Inc.'s (NASDAQ:AMGN) CEO Will See A Huge Pay Rise This Year
Key Insights
Amgen to hold its Annual General Meeting on 31st of MayCEO Bob Bradway's total compensation includes salary of US$1.79mTotal compensation is 35% above industry averageOver the past three years, Amgen's EPS fell by 17% and over the past three years, the total shareholder return was 42%
Despite strong share price growth of 42% for Amgen Inc. (NASDAQ:AMGN) over the last few years, earnings growth has been disappointing, which suggests something is amiss. These concerns will be at the front of shareholders' minds as they go into the AGM coming up on 31st of May. It would also be an opportunity for them to influence management through exercising their voting power on company resolutions, including CEO and executive remuneration, which could impact on firm performance in the future. From the data that we gathered, we think that shareholders should hold off on a raise on CEO compensation until performance starts to show some improvement.